Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
C17orf104 Rabbit anti-Human, Polyclonal, Bioss

Rabbit Polyclonal Antibody
Supplier: Bioss BS9837R

Description
Is required for meiosis completion in both male and female germ cells. Confers stability to numerous meiotic mRNAs in gonads allowing proper initiation and progression into meiosis prophase I. The function may involve YTHDC2 and is independent of induction by retinoic acid (RA). Maintains an extended meiotic prophase I by properly promoting the transition from a mitotic to a meiotic cell cycle program by binding transcripts through its interaction with YTHDC2 that regulate the mitotic cell cycle.Specifications
C17orf104 | |
Polyclonal | |
Unconjugated | |
MEIOC | |
C17orf104; C9H17orf104; chromosome 9 open reading frame, human C17orf104; Gm1564; Gm663; LOC100342231; MEIOC; meiosis specific with coiled-coil domain; Meiosis-specific coiled-coil domain-containing protein MEIOC; Meiosis-specific with coiled-coil domain protein; predicted gene 1564; RGD1563746; similar to nuclear protein with a coiled coil-4 domain of bilaterial origin like (3L720); uncharacterized LOC100342231; uncharacterized protein C17orf104; uncharacterized protein C17orf104 homolog | |
Rabbit | |
Protein A | |
RUO | |
284071 | |
-20°C | |
Liquid |
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot | |
1 μg/mL | |
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH | |
A2RUB1 | |
MEIOC | |
KLH conjugated synthetic peptide derived from human C17orf104. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction